[ Price : $8.95]
FDA approves Ariad Pharmaceuticals plan to return its leukemia drug Iclusig (ponatinib) to the market.[ Price : $8.95]
FDA approves an Xlumena de novo petition for the AXIOS Stent and Delivery System for treating pseudocysts that form in the pancrea...[ Price : $8.95]
Attorneys writing the Drug and Device Law blog urge drug and medical device companies to argue federal preemption of off-label saf...[ Price : $8.95]
Sandoz initiates a Phase 3 study of its biosimilar version of AbbVies Humira.[ Price : $8.95]
Federal Register Notice: FDA submits a proposed collection of information to the Office of Management and Budget on testing commun...[ Price : $8.95]
Federal Register Notice: FDA plans a public workshop 3/28/14: FDA/American Academy of Ophthalmology (AAO) Workshop on Developing N...[ Price : $8.95]
Federal Register Final rule: FDA modernizes its administrative regulations on submitting citizen petitions to explicitly provide f...[ Price : $8.95]
FDA Office of Commissioner crisis management director Ellen Morrison moves up to Office of Regulatory Affairs assistant commission...